Solace Therapeutics' Series E - II Round

Solace Therapeutics raised a round of funding on February 12, 2020. Investors include Spray Venture Partners.

Solace Therapeutics is a medical device company focused on the development of non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive b…

Articles about Solace Therapeutics' Series E - II Round: